Unique Coronary Artery Disease Differences in Women as Related to Revascularization

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|31|3597-3606

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.31, 2015-10, pp. : 3597-3606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revascularization treatment of stable coronary artery disease

By Magro Michael   Garg Scot   Serruys Patrick W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 195-212

Informa Healthcare

Access to resources Recommend Favorite

Cost Considerations in Selecting Coronary Artery Revascularization Therapy in the Elderly

By David M. Maziarz   Theodore C. Koutlas  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 219-225

Adis International

Access to resources Recommend Favorite

Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 25, 2016-07 ,pp. : 3928-3934

Bentham Science Publishers

Access to resources Recommend Favorite

Low-dose hormone therapy may be beneficial in postmenopausal women with myocardial ischaemia but no obstructive coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Serum Levels of Calcitonin Gene-related Peptide and Substance P are Decreased in Patients with Diabetes Mellitus and Coronary Artery Disease

By Wang LH   Zhou SX   Li RC   Zheng LR   Zhu JH   Hu SJ   Sun YL  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 134-140

Field House Publishing

Access to resources Recommend Favorite